Tandem rises as EU clears its insulin pump for use with Lilly's fast-acting insulin

Tandem Diabetes Care

19/09/2024 15:28

** Shares of medical device maker Tandem Diabetes Care
 TNDM.O  rise 4% to $44.36  
    ** Co says its insulin pump was cleared for use with Eli
Lilly's  LLY.N  fast-acting insulin Lyumjev® in the European
Union (EU) 
    ** The insulin pump, t:slim X2, is currently cleared for use
with Lilly's Humalog and Novo Nordisk's  NOVOb.CO 
Novolog/NovoRapid U-100 insulins globally -TNDM
     ** Lyumjev is rapid-acting mealtime insulin, which helps
control blood sugar levels after meals in adults with diabetes
    ** Including session gains, stock up ~49% YTD 

 (Reporting by Mariam Sunny in Bengaluru)
 ((Mariam.ESunny@thomsonreuters.com;))